Heart drug trial aims to halt Parkinson's before symptoms start
Disease control
Ongoing
This study is testing if a common heart medication, carvedilol, can slow or prevent the progression of Parkinson's disease in people at high risk. It focuses on individuals with a specific sleep disorder (REM sleep behavior disorder) and other early warning signs. Researchers wil…
Phase: PHASE2 • Sponsor: Michele Tagliati, MD • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC